PSNC Deploys ADVA Optical Networking 96-Channel 100G Core

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
95
PSNC Deploys ADVA Optical Networking 96-Channel 100G Core Solution in Pan-European Research Network

ADVA FSP 3000 With ROADM Technology Connects Polish Supercomputing Center to CERN

Poznan, Poland. April 11, 2017. ADVA Optical Networking today announced that the Poznan Supercomputing and Networking Center (PSNC) has deployed the ADVA FSP 3000 with 100Gbit/s core technology in its PIONIER network. PIONIER, one of Europe's largest research and education networks, links high-performance computer centers in five cities across Poland, as well as connecting the country to the European Organization for Nuclear Research (CERN) in Geneva. The new 96-channel 100Gbit/s coherent long-haul solution enables Europe's scientific community to share enormous data sets and collaborate using advanced high-bandwidth applications. Installation and maintenance work was conducted by Alma SA, the Polish systems integrator and long-term ADVA Optical Networking partner.

"Upgrading PIONIER to 100Gbit/s connectivity is a huge boost to research and education institutions across Europe. This incredibly powerful and dynamic long-haul network built on the ADVA FSP 3000 will help to accelerate the cycle of scientific discovery," said Maciej Stroinski, technical director, PSNC. "Now, research centers including CERN, home to the world's largest and most complex scientific instruments, can quickly and efficiently transport huge sets of data to supercomputers where it can be analyzed. With such an enormous increase in broadband capacity, scientists and academics will be able to further push the boundaries of what's possible from advances in particle physics to understanding the origins of our universe."

The new fully redundant GMPLS-based network connects Polish supercomputing centers in Poznan, Gdansk, Warsaw, Krakow and Wroclaw. It features 96 channels and has a reach of more than 3,466km without signal regeneration. As well as ADVA FSP 3000 core transport technology, the solution utilizes ADVA Optical Networking's colorless, directionless and flexgrid multi-degree ROADMs . These create remote cross-connections on the optical layer to boost availability and simplify operations. PIONIER was one of the first national academic networks in Europe to leverage its own 10Gbit/s dark fiber network. Now, all links in the meshed infrastructure can transport 100Gbit/s and the modular design of the ADVA FSP 3000 means the network is ready to scale to 400Gbit/s and beyond in the future.

"Our technology is helping to propel international collaboration and scientific exploration. By working closely with PSNC and our partner ALMA SA, we've created a reliable, dynamic and ultra-fast network that will enable many of the world's most innovative research teams to realize their technological ambitions," commented Ardashes Garabedian, senior sales manager, Eastern Europe and CIS, ADVA Optical Networking. "Our FSP 3000 combines agile core transport functionality with massive scalability and superb ease of use. It will be a vital tool in some of the world's most advanced research projects. Also key are our directionless, colorless and gridless ROADMs, which will give researchers the power to quickly and easily set up new services, providing even more freedom for exploration and discovery."

Watch this video for information on the ADVA FSP 3000: http://adva.li/3dfsp3000 .

###

About ADVA Optical Networking ADVA Optical Networking is a company founded on innovation and driven to help our customers succeed. For over two decades, our technology has empowered networks across the globe. We're continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It's these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today's society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at: www.advaoptical.com .

About Poznan Supercomputing and Networking Center PSNC, affiliated to the Institute of Bioorganic Chemistry of the Polish Academy of Sciences, was founded in 1993 to build and develop computer infrastructure for science and education in Poznan and in Poland. This infrastructure includes metropolitan network POZMAN, High Performance Computing (HPC) Center, as well as the national broadband network PIONIER, providing the Internet and network services on international, domestic and local levels. PSNC is managing research and development within the field of new generation computer networks, high performance - parallel and distributed - computations and archive systems and cloud computing technologies, as well as green ICT, future Internet technologies & ideas, network safety, innovative applications, creating, storing and managing digital content. Since PSNC is a public entity, within its sphere of interests is the development of solutions for e-government, education, medicine, new media & communications. For more information please visit us at: www.psnc.pl .

Published By: ADVA Optical Networking SE, Munich, Germany www.advaoptical.com

For Press: Gareth Spence t +44 1904 699 358 public-relations(at)advaoptical.com

For Investors: Stephan Rettenberger t +49 89 890 665 854 investor-relations(at)advaoptical.com

PSNC Public Relations : t +48 61 858 21 34 pr(at)man.poznan.pl

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading